Market Exclusive

CryoLife, Inc. (NYSE:CRY) reported earnings of $0.12 per share beating Walls Streets expectations.

CryoLife, Inc. (NYSE:CRY) reported Q2 2017 earnings this Afternoon, coming in at $0.12 per share, beating Wall Street’s estimates of $0.10 per Share. Revenue for the quarter came in at $47.80 million beating analyst estimates of $47.02 million

Analyst Coverage For CryoLife, Inc. (NYSE:CRY)
These are 4 Buy Ratings .
The current consensus rating for CryoLife, Inc. (NYSE:CRY) is Buy (Score: 3.00) with a consensus target price of $20.75 , a potential (5.33% upside)Recent Insider Trading for CryoLife, Inc. (NYSE:CRY)

Dividend History for CryoLife, Inc. (NYSE:CRY)

Recent Trading for CryoLife, Inc. (NYSE:CRY) Shares of CryoLife, Inc. closed the previous trading session at 19.70 up +0.55 2.87% with 154,366 shares trading hands.

Exit mobile version